首页 > 市场调查报告书 > 製药

动物用医药

市场调查报告书

商品编码

1509241

动物用药品复合市场：依药物类别、动物类型、配方及地区划分

Veterinary Drugs Compounding Market, By Drug Class, By Animal Type, By Formulation, By Geography

出版日期: 2024年06月13日 | 出版商:

Coherent Market Insights | 英文 224 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024年全球动物用药品復配市值将达21亿美元，预计2031年将达38.1亿美元，2024年至2031年复合年增长率为8.9%。

图 1. 2024 年动物用药品市场占有率（%），依地区划分

动物用药品配製在兽医学中发挥重要作用，可以根据个别动物患者的需求定製药物製剂。当 FDA核准的药物不存在患者所需的适当浓度或剂型时，最常使用它们。组合药物可以根据宠物的体型、年龄和健康状况等因素制定定製药物和剂量。这种灵活的药物治疗方法可以帮助改善许多动物的治疗结果。

市场动态：

全球动物用药品復配市场的成长是由过去几年宠物拥有率上升和宠物照护支出增加等因素所推动的。提高宠物饲主为宠物提供个人化医疗照护的意识是市场成长的驱动力。然而，复合药物缺乏监管和品质标准带来了安全风险，并可能阻碍市场成长。复方药物剂量和剂型的灵活性等优势为市场参与者提供了有利可图的机会。 FDA 最近加强对这些设施的品质监控的指导方针可能会推动市场成长。

本研究的主要特点

该报告对全球动物用药品复方市场进行了详细分析，包括以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和复合年增长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球动物用药品製剂市场的主要企业。
该报告的见解将帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
动物用药品製剂的全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球动物用药品製剂市场的各种策略矩阵，将有助于相关人员做出决策。

公司简介
- Wedgewood Pharmacy
- Diamondback Drugs LL
- Stokes Pharmacy
- MEDISCA
- Patterson Companies, Inc.
- Boehringer Ingelheim
- Zoetis Inc.
- Covetrus
- Virbac
- Dechra Pharmaceuticals PLC
- Elanco
- Kindred Biosciences, Inc.
- Merck &Co., Inc.
- Bayer AG
- Putney, Inc.
- Norbrook Laboratories Limited
- Vetoquinol SA
- Ceva Sante Animale
- Rood and Riddle Veterinary Pharmacy
- Mwi Veterinary Supply Co.

第10章分析师建议

命运之轮
分析师观点
Coherent Opportunity Map

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI4796

Global veterinary drugs compounding market is estimated to be valued at USD 2.1 Bn in 2024 and is expected to reach USD 3.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.

Figure 1. Veterinary Drugs Compounding Market Share (%), By Region, 2024

Veterinary Drugs Compounding Market - IMG1

Compounded medications play an important role in veterinary medicine by allowing for customized medication preparations tailored to individual animal patients' needs. These are most commonly used when an FDA-approved drug may not exist in the appropriate strength or dosage form required for a patient. Compounded drugs allow veterinarians to create customized medications and doses depending on factors like pet's size, age, or medical condition. This flexible approach to medication can help improve treatment outcomes for many animals.

Market Dynamics:

Global veterinary drugs compounding market growth is driven by factors such as rising pet ownership and increased spending on pet care over the past few years. Growing awareness among pet owners about providing customized medical care to their animals can drive the market growth. However, lack of regulation and quality standards for compounded drugs poses safety risks and can hamper the market growth. Advantages like flexibility in dosages and forms for compounded drugs present lucrative opportunities for market players. Recent FDA guidelines to strengthen quality oversight of these facilities could drive the market growth.

Key features of the study:

This report provides in-depth analysis of the global veterinary drugs compounding market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary drugs compounding market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Patterson Veterinary, Chase Pharmaceuticals, Kentucky Performance Products, Animal Medics and Rx3 Compounding
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary drugs compounding market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary drugs compounding market.

Detailed Segmentation-

By Drug Class
- CNS Agents
- Anti-infective Agents
- Hormones and Substitutes
- Anti-inflammatory Agents
- Others
By Animal Type
- Companion Animals
- Dogs
- Cat
- Others
- Livestock Animals
By Formulation
- Oral
- Injectable
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Wedgewood Pharmacy
- Diamondback Drugs LL
- Stokes Pharmacy
- MEDISCA
- Patterson Companies, Inc.
- Boehringer Ingelheim
- Zoetis Inc.
- Covetrus
- Virbac
- Dechra Pharmaceuticals PLC
- Elanco
- Kindred Biosciences, Inc.
- Merck & Co., Inc.
- Bayer AG
- Putney, Inc.
- Norbrook Laboratories Limited
- Vetoquinol S.A.
- Ceva Sante Animale
- Rood and Riddle Veterinary Pharmacy
- Mwi Veterinary Supply Co.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Animal Type
- Market Snapshot, By Formulation
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Veterinary Drugs Compounding Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Veterinary Drugs Compounding Market, By Drug Class, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
CNS Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Anti-infective Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hormones and Substitutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Anti-inflammatory Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Veterinary Drugs Compounding Market, By Animal Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Companion Animals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Dogs
Cat
Others
Livestock Animals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Veterinary Drugs Compounding Market, By Formulation, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Veterinary Drugs Compounding Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Wedgewood Pharmacy
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Diamondback Drugs LL
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Stokes Pharmacy
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- MEDISCA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Patterson Companies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zoetis Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Covetrus
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Virbac
- Dechra Pharmaceuticals PLC
- Elanco
- Kindred Biosciences, Inc.
- Merck & Co., Inc.
- Bayer AG
- Putney, Inc.
- Norbrook Laboratories Limited
- Vetoquinol S.A.
- Ceva Sante Animale
- Rood and Riddle Veterinary Pharmacy
- Mwi Veterinary Supply Co.

10. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

动物用药品复合市场：依药物类别、动物类型、配方及地区划分